Background. Carcinoembryonic antigen (CEA) is an oncofetal glycoprotein involved in cell recognition and adhesion. Serum CEA has been extensively studied as a potential chemical marker for malignancy, most notably in patients with colon carcinoma. Serum CEA measurements have not been reported for pa
Elevated levels of squamous cell carcinoma antigen in patients with a benign disease of the skin
β Scribed by Jitze M. Duk; Pieter C. van Voorst Vader; Klaske A. Ten Hoor; Harry Hollema; Henk M. G. Doeglas; Henk W. A. de Bruijn
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 505 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
To clarify whether serum aldolase A is a useful biomarker for renal cell carcinoma (RCC), we determined serum levels of the aldolase A isozyme by an enzyme immunoassay in patients suffering from RCC, other urological tumors, and benign urological diseases. Forty-six of 126 patients with RCC (37%) ha
## Abstract ## BACKGROUND Optimal timing of the measurement of serum squamous cell carcinoma (SCC) antigen during radiation therapy (RT) and its significance for predicting the response of cervical carcinoma patients as early as possible remain unknown. ## METHODS Sixtyβthree patients with SCC o
## Abstract Expression levels of hTERT mRNA were investigated by RTβPCR in tissue specimens of patients with (Group A) and without (Group B) clinically overt bronchial carcinoma, respectively. Bronchial carcinoma (__n__ = 9) and distant normal (__n__ = 9) specimens were analyzed in Group A. The cha